HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interleukin-1 receptor antagonist intron 2 variable number of tandem repeats polymorphism and respiratory failure in children with community-acquired pneumonia.

AbstractOBJECTIVE:
To determine whether the variable nucleotide tandem repeat polymorphism in intron 2 of the interleukin-1 receptor antagonist gene is associated with lung injury in children with community-acquired pneumonia.
DESIGN:
A prospective cohort of children diagnosed with community-acquired pneumonia.
SETTING:
Two pediatric hospitals.
PATIENTS:
Eight hundred fifty pediatric patients with community-acquired pneumonia were enrolled.
INTERVENTIONS:
Genotyping of the variable nucleotide tandem repeat polymorphism in intron 2 of the interleukin-1 receptor antagonist gene was performed on DNA isolated from whole blood.
MEASUREMENTS AND MAIN RESULTS:
The requirement for positive pressure ventilation or the diagnosis of acute lung injury or acute respiratory distress syndrome were the main outcomes of the study. Children (14 days-19 yrs) with community-acquired pneumonia (850) were enrolled; analysis was limited to African American (515) and Caucasian (232) patients. Of the 82 patients requiring positive pressure ventilation, 44 were diagnosed with acute lung injury or acute respiratory distress syndrome. Multivariate logistic regression analyses indicated that children without a copy of the A1 allele of the variable nucleotide tandem repeat polymorphism in intron 2 of the interleukin-1 receptor antagonist gene were more likely to need positive pressure ventilation compared to those with one or two copies of this allele (odds ratio = 2.65, confidence interval, 1.02-6.90). In addition, the absence of the A1 allele also appeared to be associated with the development of community-acquired pneumonia-induced acute lung injury/acute respiratory distress syndrome (odds ratio = 3.1, confidence interval, 0.99-9.67).
CONCLUSIONS:
In children with community-acquired pneumonia, absence of the A1 allele at the interleukin-1 receptor antagonist intron 2 polymorphic site is associated with increased risk for more severe lung injury, as measured by the need for positive pressure ventilation or the development of acute lung injury or acute respiratory distress syndrome. Conversely, presence of the A1 allele is associated with decreased risk for more severe lung injury in this patient population.
AuthorsPallavi P Patwari, Peggy O'Cain, Denise M Goodman, Melita Smith, Julia Krushkal, Caiquin Liu, Grant Somes, Michael W Quasney, Mary K Dahmer
JournalPediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies (Pediatr Crit Care Med) Vol. 9 Issue 6 Pg. 553-9 (Nov 2008) ISSN: 1529-7535 [Print] United States
PMID18838927 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Interleukin 1 Receptor Antagonist Protein
Topics
  • Adolescent
  • Alleles
  • Child
  • Child, Preschool
  • Cohort Studies
  • Community-Acquired Infections (genetics)
  • Female
  • Gene Frequency
  • Humans
  • Infant
  • Infant, Newborn
  • Interleukin 1 Receptor Antagonist Protein (genetics)
  • Introns
  • Male
  • Minisatellite Repeats
  • Pneumonia (genetics)
  • Positive-Pressure Respiration
  • Respiratory Distress Syndrome (genetics, therapy)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: